Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update for JNJ-64565111 in severely obese participants with type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• JNJ-64565111

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Obesity and Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07